Early blood protein clues could identify children at risk of cardiometabolic disease

Researchers at Vanderbilt Health, UTHealth Houston and the University of North Carolina at Chapel Hill have identified early signs of cardiovascular-kidney-metabolic disease (CKMD) in children as young as 8 years old that potentially can be reversed with a new class of weight-loss drugs widely used by adults.

Read it at Medical Xpress ↗

← Front page